Revolution Medicines (RVMDW) EPS (Diluted) (2020 - 2026)
Revolution Medicines (RVMDW) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 0.15 |
| 10 | Revolution Medicines | 2.49 Bn | 2.49 Bn | - | -3.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.06 |
| Mar 31, 2026 | -2.29 |
| Dec 31, 2025 | -1.92 |
| Sep 30, 2025 | -1.61 |
| Jun 30, 2025 | -1.31 |
| Mar 31, 2025 | -1.13 |
| Dec 31, 2024 | -1.16 |
| Sep 30, 2024 | -0.94 |
| Jun 30, 2024 | -0.81 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -1.43 |
| Sep 30, 2023 | -0.99 |
| Jun 30, 2023 | -0.92 |
| Mar 31, 2023 | -0.72 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -0.78 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -0.72 |